{
    "organizations": [],
    "uuid": "3263d2ea1d8c5ebeb90c671fe2287e296184de1c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-teva-says-fremanezumab-marketing-a/brief-teva-says-fremanezumab-marketing-authorization-application-accepted-by-ema-idUSFWN1PS10P",
    "ord_in_thread": 0,
    "title": "BRIEF-Teva Says Fremanezumab Marketing Authorization Application Accepted By EMA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 2 (Reuters) - Teva Pharmaceutical Industries Ltd :\n* EUROPEAN MEDICINES AGENCY (EMA) ACCEPTS FREMANEZUMAB MARKETING AUTHORIZATION APPLICATION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-02T23:37:00.000+02:00",
    "crawled": "2018-02-03T21:38:14.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "teva",
        "pharmaceutical",
        "industry",
        "ltd",
        "european",
        "medicine",
        "agency",
        "ema",
        "accepts",
        "fremanezumab",
        "marketing",
        "authorization",
        "application",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}